Your browser doesn't support javascript.
loading
Clinical advantages of nebivolol in the treatment of hypertension / 中国药房
China Pharmacy ; (12): 2044-2048, 2023.
Article em Zh | WPRIM | ID: wpr-980604
Biblioteca responsável: WPRO
ABSTRACT
β-blocker is one of the commonly used anti-hypertensive drugs, and there are obvious differences in the selection of this class of drugs. Nebivolol is a third-generation β-blocker with a unique mechanism of action. This article summarizes the clinical application of nebivolol in anti-hypertensive treatment in recent years, and it is found that compared with other β-blockers, nebivolol has certain clinical treatment advantages. In addition to having a significant antihypertensive effect, it also has little impact on sexual function and heart rate of patients, and does not affect the blood glucose and lipid metabolism, so the drug is more suitable for some special groups of patients, including sexually active male hypertensive patients, hypertensive patients with complications such as type 2 diabetes mellitus and metabolic syndrome.
Palavras-chave
Texto completo: 1 Base de dados: WPRIM Idioma: Zh Revista: China Pharmacy Ano de publicação: 2023 Tipo de documento: Article
Texto completo: 1 Base de dados: WPRIM Idioma: Zh Revista: China Pharmacy Ano de publicação: 2023 Tipo de documento: Article